title: [Update on the use of PET radiopharmaceuticals in inflammatory disease].
abstract: The use of molecular imaging with PET/CT technology using different radiotracers, especially the (18)F-FDG is currently spreading beyond the area of oncology, the most interest being placed on inflammatory and infectious diseases. This article presents a review of its contribution in different inflammatory conditions in the context of structural and conventional nuclear medicine imaging. Special emphasis is placed on the more significant diseases such as large-vessel vasculitis, sarcoidosis, rheumatoid arthritis and inflammatory bowel disease and the study of the atheroma plaque.
authors.affiliation: Servicio de Medicina Nuclear, Hospital Universitario «Marqués de Valdecilla», Universidad de Cantabria, Santander, España. Electronic address: mimartinez@humv.es.
authors.forename: I
authors.initials: I
authors.lastname: Martínez-Rodríguez
authors.forename: J M
authors.initials: JM
authors.lastname: Carril
mesh_terms: D001172:Arthritis, Rheumatoid / Q000000981:diagnostic imaging*; D019788:Fluorodeoxyglucose F18; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000175:diagnosis*; D064847:Multimodal Imaging; D049268:Positron-Emission Tomography; D019275:Radiopharmaceuticals; D012507:Sarcoidosis / Q000175:diagnosis*; D014057:Tomography, X-Ray Computed; D014657:Vasculitis / Q000175:diagnosis*
chemical_list: D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18
keywords: (18)F-FDG PET/CT; (18)F-FDG PET/TC; Artritis reumatoide; Ateromatosis; Atheromatosis; Inflamación; Inflammation; Large vessel vasculitis; Rheumatoid arthritis; Sarcoidosis; Vasculitis de grandes vasos